Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProDex-POCD: Sedation Effects on Cognitive Dysfunction in Fracture Surgery
NCT05398757Withdrawn
- Sponsor
- Osijek University Hospital Centre
- Start
- Jul 2022
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of dexmedetomidine in Post-operative cognitive dysfunction (POCD) (3 arms), sponsored by Osijek University Hospital Centre. Primary endpoints: Mini Mental State Examination at 5 days, Digit Symbol Substitution Test at 5 days and 5 more. Planned start Jul 2022; status: withdrawn.
02
Drugs
dexmedetomidine
03
Conditions
Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT05398757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05398757.